Lev Lichtenstein

1.4k total citations
24 papers, 989 citations indexed

About

Lev Lichtenstein is a scholar working on Genetics, Molecular Biology and Surgery. According to data from OpenAlex, Lev Lichtenstein has authored 24 papers receiving a total of 989 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 8 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in Lev Lichtenstein's work include Inflammatory Bowel Disease (12 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Heat shock proteins research (5 papers). Lev Lichtenstein is often cited by papers focused on Inflammatory Bowel Disease (12 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Heat shock proteins research (5 papers). Lev Lichtenstein collaborates with scholars based in Israel, United States and Japan. Lev Lichtenstein's co-authors include Eugene B. Chang, Iris Dotan, Yehuda Chowers, Yulia Ron, Shomron Ben‐Horin, Ofer Ben‐Bassat, Gerald Fraser, Batia Weiss, Yunwei Wang and Irit Avni‐Biron and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Lev Lichtenstein

24 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lev Lichtenstein Israel 14 451 349 332 258 188 24 989
Cornelia Lichtenberger Austria 16 373 0.8× 264 0.8× 568 1.7× 270 1.0× 128 0.7× 26 1.2k
Lani Prideaux Australia 11 725 1.6× 572 1.6× 265 0.8× 139 0.5× 333 1.8× 25 1.1k
Astrid Konrad Germany 18 506 1.1× 334 1.0× 241 0.7× 712 2.8× 198 1.1× 26 1.3k
K-H MEYER ZUM BÜSCHENFELDE Germany 10 483 1.1× 307 0.9× 388 1.2× 522 2.0× 204 1.1× 10 1.4k
Annamaria Pronio Italy 19 420 0.9× 271 0.8× 221 0.7× 213 0.8× 444 2.4× 53 1.2k
David Kevans Ireland 18 374 0.8× 333 1.0× 424 1.3× 125 0.5× 295 1.6× 58 1.3k
Melania Scarpa Italy 20 287 0.6× 202 0.6× 450 1.4× 573 2.2× 387 2.1× 53 1.4k
Daniele Corridoni United States 19 350 0.8× 155 0.4× 602 1.8× 547 2.1× 208 1.1× 31 1.2k
Kazunori Sugi Japan 15 235 0.5× 165 0.5× 322 1.0× 176 0.7× 356 1.9× 26 909

Countries citing papers authored by Lev Lichtenstein

Since Specialization
Citations

This map shows the geographic impact of Lev Lichtenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lev Lichtenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lev Lichtenstein more than expected).

Fields of papers citing papers by Lev Lichtenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lev Lichtenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lev Lichtenstein. The network helps show where Lev Lichtenstein may publish in the future.

Co-authorship network of co-authors of Lev Lichtenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Lev Lichtenstein. A scholar is included among the top collaborators of Lev Lichtenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lev Lichtenstein. Lev Lichtenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Har‐Noy, Ofir, et al.. (2020). Covid-19 post-lockdown: A transparent box, used as protective equipment in gastroscopy. A test of feasibility and efficacy. Digestive and Liver Disease. 53(1). 13–16. 1 indexed citations
2.
Kopylov, Uri, Yulia Ron, Irit Avni‐Biron, et al.. (2017). Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience. Inflammatory Bowel Diseases. 23(3). 404–408. 82 indexed citations
3.
Lichtenstein, Lev, et al.. (2017). P478 The current place of probiotics in treatment of pouchitis: systematic review. Journal of Crohn s and Colitis. 11(suppl_1). S321–S322. 25 indexed citations
4.
Lichtenstein, Lev, Doron Boltin, Haim Leibovitzh, et al.. (2017). H. Pylori and IBD are Inversely Related, Suggesting that Individuals Infected with the Bacteria are Less Susceptible to the Disease. Gastroenterology. 152(5). S971–S971. 1 indexed citations
5.
Lichtenstein, Lev, Doron Boltin, Tsachi Tsadok Perets, et al.. (2017). P708 Helicobacter pylori and IBD are inversely related, suggesting that individuals infected with the bacteria are less susceptible to the disease. Journal of Crohn s and Colitis. 11(suppl_1). S442–S444. 1 indexed citations
6.
Niv, Yaron, et al.. (2016). Capsule Endoscopy Crohn’s Disease Activity Index (CECDAIic or Niv Score) for the Small Bowel and Colon. Journal of Clinical Gastroenterology. 52(1). 45–49. 24 indexed citations
7.
Lichtenstein, Lev, Irit Avni‐Biron, & Ofer Ben‐Bassat. (2016). The current place of probiotics and prebiotics in the treatment of pouchitis. Best Practice & Research Clinical Gastroenterology. 30(1). 73–80. 7 indexed citations
8.
Uchiyama, Kazuhiko, Toshio Sakiyama, Mark W. Musch, et al.. (2016). Butyrate and bioactive proteolytic form of Wnt-5a regulate colonic epithelial proliferation and spatial development. Scientific Reports. 6(1). 32094–32094. 28 indexed citations
9.
Lichtenstein, Lev, Irit Avni‐Biron, & Ofer Ben‐Bassat. (2016). Probiotics and prebiotics in Crohn's disease therapies. Best Practice & Research Clinical Gastroenterology. 30(1). 81–88. 46 indexed citations
10.
Fraser, Gerald, Yoram Rosenbach, Raanan Shamir, et al.. (2016). Mo1869 Early Outcomes for Adolescent Crohn's Disease Patients Treated in a Transition Clinic. Gastroenterology. 150(4). S800–S800. 1 indexed citations
11.
Lichtenstein, Lev, Yulia Ron, Shmuel Kivity, et al.. (2015). Infliximab-Related Infusion Reactions: Systematic Review. Journal of Crohn s and Colitis. 9(9). 806–815. 159 indexed citations
12.
Boltin, Doron, Rachel Gingold‐Belfer, Lev Lichtenstein, Zohar Levi, & Yaron Niv. (2014). Long-term treatment outcome of patients with gastric vascular ectasia treated with argon plasma coagulation. European Journal of Gastroenterology & Hepatology. 26(6). 588–593. 22 indexed citations
13.
Yanai, Henit, Lev Lichtenstein, Amit Assa, et al.. (2014). Levels of Drug and Antidrug Antibodies Are Associated With Outcome of Interventions After Loss of Response to Infliximab or Adalimumab. Clinical Gastroenterology and Hepatology. 13(3). 522–530.e2. 236 indexed citations
14.
Yanai, Henit, Lev Lichtenstein, Amit Assa, et al.. (2014). Su1121 Anti-TNF and Anti-Drug Antibodies Levels Predict the Outcomes of Interventions After Loss of Response to Adalimumab and Infliximab. Gastroenterology. 146(5). S–381. 1 indexed citations
15.
Harrell, Laura, Yunwei Wang, Dionysios A. Antonopoulos, et al.. (2012). Standard Colonic Lavage Alters the Natural State of Mucosal-Associated Microbiota in the Human Colon. PLoS ONE. 7(2). e32545–e32545. 124 indexed citations
16.
Hu, Shien, Yunwei Wang, Lev Lichtenstein, et al.. (2010). Regional differences in colonic mucosa-associated microbiota determine the physiological expression of host heat shock proteins. American Journal of Physiology-Gastrointestinal and Liver Physiology. 299(6). G1266–G1275. 45 indexed citations
17.
Hu, Shien, Xiaorong Zhu, Joseph Triggs, et al.. (2009). Inflammation-induced, 3′UTR-dependent translational inhibition of Hsp70 mRNA impairs intestinal homeostasis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 296(5). G1003–G1011. 25 indexed citations
18.
Tao, Yun, John Hart, Lev Lichtenstein, et al.. (2008). Inducible heat shock protein 70 prevents multifocal flat dysplastic lesions and invasive tumors in an inflammatory model of colon cancer. Carcinogenesis. 30(1). 175–182. 29 indexed citations
19.
Delgado, Jorge, Reba Mustafi, Jason R. Yee, et al.. (2008). Sorafenib Triggers Antiproliferative and Pro-Apoptotic Signals in Human Esophageal Adenocarcinoma Cells. Digestive Diseases and Sciences. 53(12). 3055–3064. 24 indexed citations
20.
Hu, Shien, Mae J. Ciancio, Maor Lahav, et al.. (2007). Translational Inhibition of Colonic Epithelial Heat Shock Proteins by IFN-γ and TNF-α in Intestinal Inflammation. Gastroenterology. 133(6). 1893–1904. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cornelia Lichtenberger Breakdown of academic impact, for papers by Lani Prideaux Breakdown of academic impact, for papers by Astrid Konrad Breakdown of academic impact, for papers by K-H MEYER ZUM BÜSCHENFELDE Breakdown of academic impact, for papers by Annamaria Pronio Breakdown of academic impact, for papers by David Kevans Breakdown of academic impact, for papers by Melania Scarpa Breakdown of academic impact, for papers by Daniele Corridoni Breakdown of academic impact, for papers by Kazunori Sugi
Rankless by CCL
2026